| Attribute |
Value |
Sources |
| Symbol |
EPHB6 |
|
| Name |
Ephrin Type-B Receptor 6 |
|
| Chromosome |
7q34 |
|
| NCBI Gene ID |
2051 |
|
| UniProt ID |
Q9WWP6 |
|
| Gene Type |
Protein coding (receptor tyrosine kinase) |
|
| Kinase Activity |
Low/Inactive |
[@efrin-receptors] |
EPHB6 (Ephrin Type-B Receptor 6) is a member of the Eph receptor tyrosine kinase family, distinguished by its atypical kinase activity. Unlike other EPH receptors that have robust tyrosine kinase activity, EPHB6 has very low or undetectable kinase activity, making it uniquely positioned to function primarily as a receptor for ephrin-B ligands without triggering strong forward signaling [@efrin-receptors].
This unique property enables EPHB6 to participate in "reverse signaling" through its ephrin-B ligands, where the ligand, rather than the receptor, transduces signals into the cell expressing it. This bidirectional signaling mode is particularly relevant in the immune system and in neuronal development, where EPHB6 plays important roles in cell-cell communication, synaptic function, and immune regulation [@efrin-signaling].
In the context of neurodegenerative diseases, EPHB6's roles in synaptic maintenance, neuroprotection, and immune modulation make it a molecule of interest for understanding disease mechanisms and developing therapeutic approaches for conditions like Alzheimer's disease (AD) and Parkinson's disease (PD).
¶ Receptor-Ligand Interactions
EPHB6 binds to ephrin-B ligands:
1. Ligand Binding
- Primary ligands: EFNB1 (ephrin-B1), EFNB2 (ephrin-B2), EFNB3 (ephrin-B3)
- Binds with different affinities to each ligand
- Interaction triggers bidirectional signaling
2. Forward Signaling (Limited)
- EPHB6 has minimal kinase activity
- Limited forward signaling compared to other EPH receptors
- May still recruit adapter proteins
3. Reverse Signaling
- Primary mode of EPHB6-mediated signaling
- Ephrin-B ligands transduce signals into expressing cells
- Regulates cellular responses in both neurons and immune cells
EPHB6-associated signaling includes:
| Pathway |
Type |
Function |
| MAPK/ERK |
Forward (weak) |
Cell growth/differentiation |
| Rho GTPases |
Reverse |
Cytoskeletal dynamics |
| PI3K/Akt |
Reverse |
Survival signaling |
| JAK/STAT |
Reverse |
Immune regulation |
EPHB6 distinguishes itself from other EPH receptors:
- Kinase deficiency: Minimal autophosphorylation activity
- Dominant-negative behavior: May regulate other EPH receptors
- Immune enrichment: Higher expression in immune cells
- Tissue specificity: Distinct expression patterns
EPHB6 contributes to AD through synaptic and developmental mechanisms [@efrin-ad]:
1. Synaptic Dysfunction
- Ephrin-EPH signaling regulates synapse formation and maintenance
- EPHB6 deficiency may contribute to synaptic loss
- Early synaptic deficits in AD involve ephrin dysregulation
2. Developmental Links
- Brain developmental pathways often reactivated in neurodegeneration
- EPHB6-mediated developmental signaling may be dysregulated
- Could contribute to network dysfunction
3. Tau Pathology Interaction
- Ephrin signaling can intersect with tau pathology
- May affect tau-induced synaptic dysfunction
4. Neuroprotective Potential
- EPHB6 reverse signaling can be neuroprotective
- Loss of protective signaling contributes to degeneration
EPHB6 contributes to PD through [@efrin-pd]:
1. Dopaminergic Development
- EPHB6 is expressed during dopaminergic neuron development
- May be relevant to vulnerability of substantia nigra neurons
2. Synaptic Function
- Regulates striatal synapse formation and function
- Dysregulation affects basal ganglia circuits
3. Neuroinflammation
- EPHB6 is expressed in immune cells
- Modulates inflammatory responses
- Contributes to neuroinflammation in PD
4. Axonal Guidance
- Axonal pathfinding requires ephrin signaling
- May affect circuit establishment and maintenance
EPHB6 changes in ALS:
- Motor neuron development involves EPHB6
- May contribute to selective motor neuron vulnerability
EPHB6 has significant immune relevance [@efrin-immune]:
1. T Cell Function
- Regulates T cell activation and migration
- Modulates immune responses
- Relevant to neuroinflammation
2. Macrophage/Microglial Activity
- Affects phagocytic activity
- Modulates cytokine production
- Central to neuroinflammation control
3. Antigen Presentation
- Regulates dendritic cell function
- Affects immune surveillance
EPHB6 shows distinct expression patterns:
- Brain: Cortex, hippocampus, cerebellum, basal ganglia
- Immune system: High in T cells, monocytes, dendritic cells
- Peripheral tissues: Lower expression
In the brain:
- Neurons (moderate expression)
- Glia (lower expression)
- Particularly in regions with synaptic activity
¶ Ligands
- EFNB1 (ephrin-B1)
- EFNB2 (ephrin-B2)
- EFNB3 (ephrin-B3)
- Rho family GTPases
- PI3K
- MAPK pathway components
- CD3 (T cells)
- CD14 (monocytes)
- CD11c (dendritic cells)
EPHB6-based therapeutic approaches:
- Modulate reverse signaling: Enhance protective ephrin-B signaling
- Immune modulation: Target neuroinflammation via EPHB6
- Synaptic protection: Preserve synaptic function
- Developmental pathways: Target dysregulated developmental genes
flowchart TD
subgraph EPHB6_Functions
A["EPHB6 Gene"] --> B["EPHB6 Protein"]
B --> C["Ephrin-B<br/>Binding"]
C --> D["Reverse<br/>Signaling"]
C --> E["Forward<br/>Signaling<br/>(Weak)"]
end
subgraph Signal_Transduction
D --> F["Rho GTPases<br/>Cytoskeleton"]
D --> G["PI3K/Akt<br/>Survival"]
E --> H["MAPK/ERK<br/>Growth"]
end
subgraph Synaptic_Function
F --> I["Synapse<br/>Organization"]
G --> J["Synaptic<br/>Protection"]
end
subgraph Immune_Function
K["Immune Cells"] --> L["T Cell<br/>Regulation"]
K --> M["Microglial<br/>Modulation"]
L --> N["Inflammatory<br/>Response"]
end
subgraph Disease_Mechanisms
O["AD/PD"] --> P["Synaptic<br/>Dysfunction"]
O --> Q["Neuroinflammation"]
P --> R["Cognitive<br/>Decline"]
Q --> S["Neuronal<br/>Loss"]
end
style A fill:#e3f2fd
style O fill:#ffcdd2
style R fill:#b71c1c
style S fill:#b71c1c
- EPHA2 — Related ephrin receptor
- EPHB2 — Another EPH receptor
- EFNB2 — Ephrin-B ligand